etidronate has been researched along with Colitis, Granulomatous in 7 studies
Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with Crohn's disease have an increased frequency of osteopenia and osteoporosis." | 2.77 | Risedronate improves bone mineral density in Crohn's disease: a two year randomized controlled clinical trial. ( Fedorak, RN; McQueen, B; Siffledeen, J; Siminoski, K; Soo, I, 2012) |
| "One hundred fifty-four patients with Crohn's disease with decreased bone mineral density, determined by using dual-energy x-ray absorptiometry, were randomly assigned to receive etidronate (400 mg orally) or not for 14 days; both groups were then given daily calcium (500 mg) and vitamin D (400 IU) supplementation for 76 days." | 2.71 | Randomized trial of etidronate plus calcium and vitamin D for treatment of low bone mineral density in Crohn's disease. ( Abraham, N; Fedorak, RN; Greenberg, G; Jen, H; Siffledeen, JS; Siminoski, K; Steinhart, H; Vaudan, E, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van Bodegraven, AA | 2 |
| Bravenboer, N | 1 |
| Witte, BI | 2 |
| Dijkstra, G | 1 |
| van der Woude, CJ | 1 |
| Stokkers, PC | 1 |
| Russel, MG | 1 |
| Oldenburg, B | 1 |
| Pierik, M | 1 |
| Roos, JC | 1 |
| van Hogezand, RA | 1 |
| Dik, VK | 1 |
| Oostlander, AE | 1 |
| Netelenbos, JC | 1 |
| van de Langerijt, L | 1 |
| Hommes, DW | 1 |
| Lips, P | 2 |
| Bernstein, CN | 1 |
| Targownik, LE | 1 |
| Leslie, WD | 1 |
| Buchan, A | 1 |
| Manuel, A | 1 |
| Soo, I | 1 |
| Siffledeen, J | 1 |
| Siminoski, K | 2 |
| McQueen, B | 1 |
| Fedorak, RN | 2 |
| Namazi, H | 1 |
| Siffledeen, JS | 1 |
| Jen, H | 1 |
| Vaudan, E | 1 |
| Abraham, N | 1 |
| Steinhart, H | 1 |
| Greenberg, G | 1 |
3 trials available for etidronate and Colitis, Granulomatous
| Article | Year |
|---|---|
Treatment of bone loss in osteopenic patients with Crohn's disease: a double-blind, randomised trial of oral risedronate 35 mg once weekly or placebo, concomitant with calcium and vitamin D supplementation.
Topics: Absorptiometry, Photon; Adult; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabo | 2014 |
Risedronate improves bone mineral density in Crohn's disease: a two year randomized controlled clinical trial.
Topics: Absorptiometry, Photon; Adult; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabo | 2012 |
Randomized trial of etidronate plus calcium and vitamin D for treatment of low bone mineral density in Crohn's disease.
Topics: Absorptiometry, Photon; Administration, Oral; Adult; Bone Density; Calcium; Crohn Disease; Dose-Resp | 2005 |
4 other studies available for etidronate and Colitis, Granulomatous
| Article | Year |
|---|---|
What is the role for bisphosphonates in IBD?
Topics: Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcium; Crohn Disease; Dietary Suppleme | 2014 |
The role of risedronate in osteopenia in Crohn's disease.
Topics: Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcium; Crohn Disease; Dietary Suppleme | 2015 |
Authors' response: The role of risedronate in osteopenia in Crohn's disease.
Topics: Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcium; Crohn Disease; Dietary Suppleme | 2015 |
Risedronate improves bone mineral density in Crohn's disease: a complementary mechanism.
Topics: Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Crohn Disease; Etidronic A | 2012 |